NCT07073430 Application Evaluation Research on the Artificial Intelligence-assisted Support System for the Diagnosis of Colorectal Tubular Adenoma Lesions
| NCT ID | NCT07073430 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Renmin Hospital of Wuhan University |
| Condition | Colorectal Adenoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2023-11-28 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2023-11-28 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a prospective,multi-center and observational clinical study.Investigators would like to innovatively construct a "trinity" database of colorectal tubular adenomas based on white light - magnifying chromo - pathological images.It simulates the decision - making logic of doctors, and based on the multimodal endoscopic LAFEQ method previously proposed, develop a multimodal deep - learning diagnostic model for colon adenomas and an interpretable risk prediction model for intestinal adenomas. While achieving high - precision auxiliary treatment decisions, clearly present the decision - making basis, and break through the limitation of poor interpretability of previous medical imaging AI models.
Eligibility Criteria
Inclusion Criteria: * Patients aged ≥ 18 years, who need to undergo colonoscopy, regardless of gender. * Voluntarily sign the informed consent form * Promise to abide by the research procedures and cooperate in the implementation of the entire research process. Exclusion Criteria: * Patients who has a history of abdominal or pelvic surgery or radiotherapy in the past; * Patients who has definite active lower gastrointestinal bleeding. * Existing or suspected hereditary colorectal polyposis, inflammatory bowel disease; * Uncontrolled hypertension (systolic blood pressure \> 160 mmHg or diastolic blood pressure \> 95 mmHg after standardized treatment) * There is a history of stroke, coronary artery disease, or vascular disease; * Pregnant; * Intestinal preparation cannot be carried out.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07073430 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Colorectal Adenoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07073430 currently recruiting?
Yes, NCT07073430 is actively recruiting participants. Contact the research team at kaimingchen@163.com for enrollment information.
Where is the NCT07073430 trial being conducted?
This trial is being conducted at Wuhan, China.
Who is sponsoring the NCT07073430 clinical trial?
NCT07073430 is sponsored by Renmin Hospital of Wuhan University. The trial plans to enroll 4,000 participants.